XBLCM Stock Overview
Xtrackers II - EUR Corporate Bond UCITS ETF is an exchange traded fund launched by Deutsche Asset Management S.A.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Xtrackers II - EUR Corporate Bond UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €150.24 |
52 Week High | €0 |
52 Week Low | €0 |
Beta | 0 |
1 Month Change | -0.68% |
3 Month Change | -0.013% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 3.32% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
XBLCM | GB Capital Markets | GB Market | |
---|---|---|---|
7D | 0.3% | 1.2% | 1.1% |
1Y | n/a | 6.5% | 1.9% |
Return vs Industry: Insufficient data to determine how XBLCM performed against the UK Capital Markets industry.
Return vs Market: Insufficient data to determine how XBLCM performed against the UK Market.
Price Volatility
XBLCM volatility | |
---|---|
XBLCM Average Weekly Movement | 0.5% |
Capital Markets Industry Average Movement | 4.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.5% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: XBLCM has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine XBLCM's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | n/a | n/a | n/a |
Xtrackers II - EUR Corporate Bond UCITS ETF is an exchange traded fund launched by Deutsche Asset Management S.A. It is managed by State Street Global Advisors Limited. The fund invests in the fixed income markets across the globe.
Xtrackers II - EUR Corporate Bond UCITS ETF Fundamentals Summary
XBLCM fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs XBLCM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
XBLCM income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did XBLCM perform over the long term?
See historical performance and comparison